Skip to main content
ARTV logo

ARTV · Artiva Biotherapeutics, Inc.

$10.18 -0.35 (-3.32%)
Market Cap
$260.27M
Shares
24.72M

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

The Jun 30, 2026 filing window is still open — showing the latest known positions. Funds that have not filed yet carry their prior-quarter positions; a fund that filed without this stock counts as sold out.
Holders: 42
Total Value: $109,263,699
Total Shares: 16,914,263

Institutional Ownership Trend

8 quarters

Holder Concentration

Across 40 13F filers
Top Holder
58.5%
Sep 2024 → Mar 2026 · range 46.6% – 58.5%
of institutional value
Top 5
88.3%
Sep 2024 → Mar 2026 · range 77.4% – 88.4%
of institutional value
Top 10
94.6%
Sep 2024 → Mar 2026 · range 91.2% – 95.3%
of institutional value
HHI
3,743
Sep 2024 → Mar 2026 · range 2,477 – 3,743
Highly concentrated
Showing 42 of 42
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 1817241 CUSIP 04317A107 13F (30d) 4 filings 4 filers Visit website Investor relations